Literature DB >> 907399

Pharmacological preservation of the ischemic heart.

R E Clark, T B Ferguson, P N West, R C Shuchleib, P D Henry.   

Abstract

This study was based on the concept that intracellular accumulation of calcium plays a role in mediating ischemic myocardial injury and that inhibition of entry of calcium into cells may have a salutary effect on the ischemic heart. Nifedipine, a potent vasodilator and inhibitor of transmembrane calcium flux, was infused into the aortic root of 6 dogs (5 microgram/kg/hr) during 2 hours of myocardial ischemia while on cardiopulmonary bypass. Seven control animals received normal saline at the same flow rate and temperature (20 degrees C). The results showed that none of the 7 control animals were able to maintain adequate aortic pressure or cardiac output after 30 to 60 minutes of normothermic reperfusion. All had marked left ventricular failure and were unresponsive to large doses of inotropic agents. In contrast, the 6 dogs treated with nifedipine were weaned from bypass either without difficulty or requiring small doses of calcium chloride and norepinephrine. Light microscopy demonstrated more marked ischemic damage in the control group than in the group of drug-treated dogs. We conclude that the concept of inhibition of transmembrane calcium flux offers a new and potent method for myocardial preservation during ischemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 907399     DOI: 10.1016/s0003-4975(10)63405-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

Authors:  Hiroshi Yamamoto; Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-23

Review 2.  The role of calcium in the ischemic myocardium.

Authors:  W G Nayler
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

3.  Laboratory and initial clinical studies of nifedipine, a calcium antagonist for improved myocardial preservation.

Authors:  R E Clark; I Y Christlieb; T B Ferguson; C S Weldon; J P Marbarger; B E Sobel; R Roberts; P D Henry; P A Ludbrook; D Biello; B K Clark
Journal:  Ann Surg       Date:  1981-06       Impact factor: 12.969

Review 4.  Protective effects of calcium antagonists against ischaemia and reperfusion damage.

Authors:  R Ferrari; O Visioli
Journal:  Drugs       Date:  1991       Impact factor: 9.546

5.  Pharmacological analysis of established ventricular fibrillation.

Authors:  E J Carlisle; J D Allen; W G Kernohan; W Leahey; A A Adgey
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Protective effect of glutamic acid on cardiac function and metabolism during cardioplegia and reperfusion.

Authors:  O I Pisarenko; E S Solomatina; I M Studneva; V E Ivanov; V I Kapelko; V N Smirnov
Journal:  Basic Res Cardiol       Date:  1983 Sep-Oct       Impact factor: 17.165

7.  Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog.

Authors:  J G Kingma; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

8.  Anoxic hypothermic cardioplegia compared to intermittent anoxic fibrillatory cardiac arrest. Clinical and metabolic experience with 1080 patients.

Authors:  S J Phillips; R H Zeff; C Kongtahworn; L A Iannone; T M Brown; D F Gordon
Journal:  Ann Surg       Date:  1979-07       Impact factor: 12.969

9.  The effect of nifedipine, a calcium channel blocker, on liver ischemia in dogs.

Authors:  F Yoshimi; M Ishimaru; M Sodeyama; T Nagao; N Kawano; Y Morioka
Journal:  Jpn J Surg       Date:  1988-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.